POMC and congenital adrenal hyperplasia: Consequently, compared with AI, patients with CAH are frequently treated with supraphysiological doses of glucocorticoids, more often receive longer-acting synthetic glucocorticoids, and, to better suppress the early morning rise in ACTH, glucocorticoids in this population are frequently given in a reverse circadian pattern, with the highest dose in the evening (324).